Clinical Trial Update: Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer

View source ↗

Summary

Update on a clinical trial evaluating gemcitabine as a single-agent maintenance chemotherapy for patients with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Xijing Hospital | Conditions: Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer, Gemcitabine | Status: UNKNOWN